CirChem AB (CRB) Financial Statements
CirChem AB Financial Overview
CirChem AB's market cap is currently $2.73M. The company's EPS TTM is $-0.45; its P/E ratio is -1.04; CirChem AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.96M | $ 20.66M | $ 5.75M | $ 590.62K | $ 85.55K |
| Gross Profit | $ -7.93M | $ 19.53M | $ 3.04M | $ 2.92M | $ 2.62M |
| Operating Income | $ -11.24M | $ 104.00K | $ -15.62M | $ -19.94M | $ -16.82M |
| EBITDA | $ -10.12M | $ 374.00K | $ -15.52M | $ -19.87M | $ -16.74M |
| Net Income | $ -12.05M | $ -1.07M | $ -17.14M | $ -25.50M | $ -19.48M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.65M | $ 11.93M | $ 16.58M | $ 9.78M | $ 14.57M |
| Total Assets | $ 69.47M | $ 61.18M | $ 59.11M | $ 50.30M | $ 52.14M |
| Total Debt | $ 20.52M | $ 8.92M | $ 8.92M | $ 1.75M | $ 2.00M |
| Net Debt | $ 6.87M | $ -11.93M | $ -7.66M | $ -8.02M | $ -12.57M |
| Total Liabilities | $ 25.14M | $ 15.49M | $ 24.00M | $ 25.17M | $ 25.77M |
| Stockholders' Equity | $ 44.33M | $ 45.68M | $ 35.10M | $ 25.13M | $ 26.37M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.57M | $ -12.85M | $ -27.48M | $ -25.27M | $ -5.47M |
| Operating Cash Flow | $ -13.70M | $ -6.38M | $ -26.68M | $ -21.49M | $ -2.78M |
| Investing Cash Flow | $ -6.88M | $ -6.47M | $ -798.49K | $ -3.78M | $ -2.69M |
| Financing Cash Flow | $ 22.29M | $ 8.20M | $ 34.29M | $ 20.48M | $ -2.04M |
Currency in SEK
